Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

A multi-targeted approach for a complex multifaceted disease.

Shineman DW, Fillit HM.

Curr Alzheimer Res. 2009 Oct;6(5):407-8. No abstract available.

PMID:
19860641
2.

New treatments in the pipeline for Alzheimer's.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2009 May;21(3):4-5. No abstract available.

PMID:
19496265
3.

Obesity and Alzheimer disease: roles of diet and genetics.

Grant WB.

Arch Intern Med. 2004 Jan 12;164(1):109-10; author reply 110. No abstract available.

PMID:
14718338
4.

[Alzheimer: role of new genes and also lack of sleep].

Casselyn M.

Rev Med Suisse. 2009 Oct 21;5(222):2124. French. No abstract available.

PMID:
19947460
5.

Your health in the 21st century. 7 ways to save a brain.

Underwood A.

Newsweek. 2005 Summer;145(26A):32-4. No abstract available.

PMID:
16375140
6.

What we have learned from the Myriad trials.

Hendrix SB, Wilcock GK.

J Nutr Health Aging. 2009 Apr;13(4):362-4. No abstract available.

PMID:
19300881
7.

[Behavioral problems in Alzheimer disease: current and future treatments].

Lebert F, Pasquier F.

Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F104-8. Review. French. No abstract available.

PMID:
19593881
8.

[Biology and pathobiology of the intramembrane proteolysis by gamma-secretase].

Tomita T.

Tanpakushitsu Kakusan Koso. 2009 Oct;54(13):1747-53. Review. Japanese. No abstract available.

PMID:
19827607
9.

Genetics: Alzheimer disease.

Dorman H, Meschino WS, Allanson J, Blaine SM, Cremin C, Gibbons CA, Honeywell C, Permaul J, Carroll JC.

Can Fam Physician. 2009 Jun;55(6):603. No abstract available.

10.

Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches.

Mahley RW, Huang Y.

Ann Neurol. 2009 Jun;65(6):623-5. doi: 10.1002/ana.21736. No abstract available.

PMID:
19557874
11.

[How long should drug therapy be continued for Alzheimer disease?].

Nakamura Y.

Seishin Shinkeigaku Zasshi. 2009;111(1):43-8. Japanese. No abstract available.

PMID:
19378499
12.

[Reevaluation of four medications indicated by the French authority in Alzheimer disease].

Capelle V.

Soins Gerontol. 2007 Nov-Dec;(68):5. French. No abstract available.

PMID:
18179028
13.

Knee-jerk dogma.

de la Torre J.

J Am Coll Surg. 2008 Apr;206(4):762-3; author reply 763. doi: 10.1016/j.jamcollsurg.2008.01.026. No abstract available.

PMID:
18387487
14.

Minor thalassemia may be a protective factor against Alzheimer?

Feily A.

Minerva Med. 2009 Aug;100(4):339. No abstract available.

PMID:
19749687
15.

If shrimps had lips, they could whistle ...

Kreis J, Kaiser T, Wieseler B.

J Am Geriatr Soc. 2009 Oct;57(10):1947; author reply 1947-8. doi: 10.1111/j.1532-5415.2009.02461.x. No abstract available.

PMID:
19807804
16.

Dimebon as a potential therapy for Alzheimer's disease.

Doody RS.

CNS Spectr. 2009 Aug;14(8 Suppl 7):14-6; discussion 16-8. Review.

PMID:
19890242
17.

CSF biomarkers: pinpointing Alzheimer pathogenesis.

Mattsson N, Blennow K, Zetterberg H.

Ann N Y Acad Sci. 2009 Oct;1180:28-35. doi: 10.1111/j.1749-6632.2009.04944.x. Review.

PMID:
19906258
18.

Combined risk effects of IDE and NEP gene variants on Alzheimer disease.

Vepsäläinen S, Helisalmi S, Mannermaa A, Pirttilä T, Soininen H, Hiltunen M.

J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1268-70. doi: 10.1136/jnnp.2008.160002.

PMID:
19864659
19.

[Final report is now available. IQWiG doubts the effectiveness of memantine].

[No authors listed]

MMW Fortschr Med. 2009 Sep 24;151(39):6. German. No abstract available.

PMID:
19831181
20.

Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.

van Exel E, Eikelenboom P, Comijs H, Frölich M, Smit JH, Stek ML, Scheltens P, Eefsting JE, Westendorp RG.

Arch Gen Psychiatry. 2009 Nov;66(11):1263-70. doi: 10.1001/archgenpsychiatry.2009.146.

PMID:
19884614

Supplemental Content

Support Center